DERMATOLOGICAL CLINICAL CONFERENCE SCIENTIFIC PROGRAM FOR THE 102nd ANNUAL SESSION CALIFORNIA MEDICAL ASSOCIATION

Gottschalk, Helen R.

doi:10.1001/archderm.1974.01630090095041

Cited by 20 publications

(3 citation statements)

References 9 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In 2013, Gordon et al 5 in the United States reported a case of spiradenoma treated using intralesional 10 mg/mL TA injection, but there was minimal improvement. Gottschalk et al 6 treated a skin adnexal tumor with intralesional 40 mg/mL TA injection. A total of 1 mL of 40 mg/mL TA aqueous suspension was injected into a single 4 cm lesion.…”

Section: Discussionmentioning

confidence: 99%

“…After one injection, the size of the tumor was reduced by 75%. 6 Steroid use in this case aimed to reduce inflammation that can be associated with pain. 5 Corticosteroids have anti-inflammatory, immunosuppressive, antiproliferative, and vasoconstrictive effects.…”

Section: Discussionmentioning

confidence: 99%

“…4 In 2013, Gordon et al 5 in the United States reported a case of spiradenoma treated using injection of triamcinolone acetonide (TA) 10 mg/mL with minimal improvement. Gottschalk et al 6 administered TA 40 mg/mL in one case of adnexal tumor with a 75% reduction in lesion size. This study aims to report a rare case of giant spiradenoma which was treated by 10 mg/mL TA injection.…”

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Efficacy of Triamcinolone Acetonide Injection in a Case of Giant Spiradenoma

Sutedja¹,

Anandita²,

Sutedja³

et al. 2022

IMCRJ

View full text Add to dashboard Cite

Spiradenoma is a rare benign adnexal tumor with eccrine differentiation. The clinical manifestations include painful, skincolored, red, gray, or bluish nodules on the upper half of the body. We report a case of spiradenoma in a 31-year-old man. The diagnosis was established from the patient's history, physical examination, and histopathological examination. In this case, the patient was treated with intralesional injection of triamcinolone acetonide (TA) 10 mg/mL. After the fourth injection, the lesions grew smaller and thinner. TA injection is easy to administer and showed good efficacy in spiradenoma case, although further research with a larger number of patients is needed.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%